drugset / Trial / NCT00512759

Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study

NCT00512759

Phase 4 Completed 781 enrolled University Hospital, Basel, Switzerland
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether an early goal-directed decrement of preload and afterload with a target systolic blood pressure of 90-110 mmHg by aggressive vasodilatation in patients with acute HF in the non-ICU setting is safe, and leads to a better clinical and economical outcome

Timeline

Start
2007-12-10
Primary completion
2018-08-24
Completion
2019-02-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan cilexetil Unknown
Subject Nitroglycerin Unknown Other
Subject Ramipril Small molecule